VTRS · Earnings call · 2026Q2T · Full report

Greater China Revenue Growth

Viatris Inc · 2026-08-06 · Importance 36 · Surprise 40 · In source text

Greater China revenue increased 16% year over year in the quarter, supported by cardiovascular products, aging-population demand and investments in selling, marketing, e-commerce and retail capabilities. Growth occurred across all channels, with e-commerce sales up 36% and representing roughly 10% to 15% of the China business. Management expects continued growth but anticipates moderation because a new procurement policy may reduce public-hospital volumes, with implementation varying across China’s 31 provinces. North America grew 1%, Europe grew 2%, emerging markets declined 2% because of ARV supply constraints, and JANZ was essentially flat amid Japanese price regulation and Australian competition.

Key facts

• Viatris expects some moderation in Greater China growth in H2 2026 due to a procurement policy change expected to negatively impact hospital channel volumes
• China e-commerce sales increased 36% year-over-year in Q2 2026
• Viatris expects to be in a position in November 2026 to speak more definitively about China policy implementation and its impact
• Greater China net sales increased 16% year-over-year in Q2 2026
• E-commerce represents roughly 10 to 15 percent of the overall China business
• China growth in 2026 first half helped Viatris raise guidance despite Nashik fire and FDA inspection observations

Impact estimates